CCNT2 and acute myeloid leukemia: Collectively, all these data implied that the miR-212-5p/CCNT2 axis may be responsible for the function of decitabine in AML, further demonstrating the potential of miR-212-5p combined with decitabine in AML treatment by inducing cell proliferation inhibition and apoptosis (Figure 9).